#news #biotech FDA accepts gefapixant for review in cough, positioning Merck to get head start on Bayer and Bellus

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FDA accepts gefapixant for review in cough, positioning Merck to get head start on Bayer and Bellus .FDA accepts gefapixant for review in cough, positioning Merck to get head start on Bayer and Bellus
ntaylor
Mon, 03/01/2021 – 08:01

from FierceBiotech: Biotech https://ift.tt/3b6mH1s